Q1 2022 Results slide image

Q1 2022 Results

Company overview Financial performance Financial review Appendix 2022 priorities Appendix Innovation: Pipeline overview Innovation: Clinical trials References Abbreviations 29 Investor Relations | Q1 2022 Results NOVARTIS | Reimagining Medicine
View entire presentation